NCT06592547View on ClinicalTrials.gov

Intravenous Metoprolol in Septic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

November 10, 2024

Conditions
Septic ShockVentilator Acquired Pneumonia
Interventions
DRUG

Intravenous metoprolol tartrate

An intravenous beta-blockers, recieved FDA approval

OTHER

Standard Care (in control arm)

Standard care according to surviving sepsis campaign

Trial Locations (1)

Unknown

Alexandria Main university hospital, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER